Clinical examples of the rational applying of the «gold standard» of hormonal therapy for endometriosis

Tikhomirov A.L.

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Sarsania S.I.

Aeterna clinic

Dedy T.V.

Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies

Osetskaya E.A.

Medical holding «CM Clinic»

Clinical examples of the rational applying of the «gold standard» of hormonal therapy for endometriosis

Authors:

Tikhomirov A.L., Sarsania S.I., Dedy T.V., Osetskaya E.A.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2021;21(4): 99‑103

DOI: 10.17116/rosakush20212104199

Downloaded: 33

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Tikhomirov AL, Sarsania SI, Dedy TV, Osetskaya EA. Clinical examples of the rational applying of the «gold standard» of hormonal therapy for endometriosis. Russian Bulletin of Obstetrician-Gynecologist. 2021;21(4):99‑103. (In Russ.)
https://doi.org/10.17116/rosakush20212104199

Подписка 2025-2 (Russian Bulletin of Obstetrician-Gynecologist)

Close metadata

Recommended articles:

Quality of life and psychosomatic status of women of reproductive age with adenomyosis. Russian Bulletin of Obstetrician-Gynecologist. 2024;(5):83-89

Controversial issues of adjuvant therapy after myomectomy. Russian Bulletin of Obstetrician-Gynecologist. 2024;(5):101-107

Predicting the effectiveness of organ-preserving treatment of choroidal melanoma using optical coherence tomography data. Russian Annals of Ophthalmology. 2024;(2-2):16-20

Endometriosis and genital malformations in children and adolescents. What do they have in common?. Russian Journal of Human Reproduction. 2024;(3):14-22

Benign breast diseases in the focus of proliferative pathology of the reproductive system. Russian Journal of Human Reproduction. 2024;(3):33-42

A clinical case of parasitic fibroids on the mesentery of the sigmoid colon. Russian Journal of Human Reproduction. 2024;(3):105-110

Tolerability of multiphasic and monophasic combined hormonal contraceptives patients with uterine fibroids. Russian Journal of Human Reproduction. 2024;(4):78-89

Pathogenetic aspects of chronic pelvic pain in endometriosis: diagnostic prospects (literature review). Russian Journal of Human Reproduction. 2024;(4):112-120

Heterogeneity of the molecular phenotype with uterine fibroids. Message I. Russian Journal of Human Reproduction. 2024;(4):121-130

The role of systemic and local immunity in the pathogenesis of endometriosis of varying degrees of prevalence of the process: a modern view. Russian Journal of Human Reproduction. 2024;(5):6-14

The publication considers the pathogenesis validity for the use of analogues of gonadotropic releasing hormone (a-GnRH) as a basic hormone therapy for endometriosis (E). Clinical examples of the rational use of locally produced a-GnRH depot-form are given. The applying of a-GnRH provides doctor with the opportunity to personalize the therapy of patients with endometriosis taking into account the clinical situation and patients’ needs including those with a combined gynecological pathology of a proliferative hormone-dependent nature. Clinical examples of applying a-GnRH «Buserelin-depot» are given.

Keywords:

endometriosis

adenomyosis

uterine fibroids

organ-preserving treatment

and a-GnRH

Authors:

Tikhomirov A.L.

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Sarsania S.I.

Aeterna clinic

Dedy T.V.

Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies

Osetskaya E.A.

Medical holding «CM Clinic»

Received:

23.06.2021

Accepted:

02.07.2021

List of references:

Miinistry of Health of the Russian Federation. Clinical recommendations. Endometriosis. 2020. (In Russ.).
Borghese B, Zondervan KT, Abrao MS, Chapron C, Vaiman D. Recent insights on the genetics and epigenetics of endometriosis. Clin Genet. 2017;91:2:254-264. https://doi.org/10.1111/cge.12897
Bouaziz J, Mashiach R, Cohen S, Kedem A, Baron A, Zajicek M, Feldman I, Seidman D, Soriano D. How artificial intelligence can improve our understanding of the genes associated with endometriosis: Natural Language Processing of the PubMed Database. Biomed Res Int. 2018;2018:6217812. https://doi.org/10.1155/2018/6217812
Zhang Z, Ruan L, Lu M, Yao X. Analysis of key candidate genes and pathways of endometriosis pathophysiology by a genomics-bioinformatics approach. Gynecol Endocrinol. 2019;35:7:576-581. https://doi.org/10.1080/09513590.2019.1576609
Gynecology. National guide. Ed. by Savel’eva G.M., Sukhikh G.T., Serov V.N., Radzinskii V.E., Manukhin I.B. M.: GEOTAR-Media; 2017. (In Russ.).
Konings G, Brentjens L, Delvoux B, Linnanen T, Cornel K, Koskimies P, Bongers M, Kruitwagen R, Xanthoulea S, Romano A. Intracrine regulation of estrogen and other sex steroid levels in endometrium and non-gynecological tissues; Pathology, Physiology, and Drug Discovery. Front Pharmacol. 2018;9:940. https://doi.org/10.3389/fphar.2018.00940
Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, Heikinheimo O, Horne AW, Kiesel L, Nap A, Prentice A, Saridogan E, Soriano D, Nelen W. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29:3:400-412.
Xholli A, FiLip G, Previtera F, Cagnacci A. Modification of endometrioma size during hormone therapy containing dienogest. Gynecol Endocrinol. 2020;36:6:545-549. https://doi.org/10.1080/09513590.2019.1703942
Maiorana A, Incandel D, Parazzini F, Alio W, Mercurio A, Giambanco L, Alio L. Efficacy of dienogest in improving pain in women with endometriosis: a 12-month single-center experience. Arch Gynecol Obstet. 2017;296:3:429-433. https://doi. org/10.1007/s00404-017-4442-5
Sugimoto K, Nagata C, Hayashi H, Yanagida S, Okamoto A. Use of dienogest over 53 weeks for the treatment of endometriosis. Journal of Obstetrics and Gynaecology Research. 2015;41:12:1921-1926.
Hirata T, Izumi G, Takamura M, Saito A, Nakazawa A, Harada M, Hirota Y. Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study. Gynecological Endocrinology. 2014;30:10:726-729.
Lee SR, Yi KW, Song JY, Seo SK, Lee DY, Cho SH, Kim SH. Efficacy and safety of long-term use of dienogest in women with ovarian endometrioma. Reproductive Sciences. 2017;25:3:341-346.
Agarwa S, Fraser MA, Chen I, Singh SS. Dienogest for the treatment of deep endometriosis: Case report and literature review. Journal of Obstetrics and Gynaecology Research. 2014;41:2:309-313.
Techatraisak K, Hestiantoro A, Ruey S, Banal-Silao MJ, Kim MR. Effectiveness of dienogest in improving quality of life in Asian women with endometriosis (ENVISIOeN): interim results from a prospective cohort study under real-life clinical practice. BMC Women’s Health. 2019;19:1:68.
Strowitzki T, Faustmann T, Gerlinger C, Schumacher U, Ahlers C, Seitz C. Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program. Int J Womens Health. 2015;7:393-401.
Tikhomirov A.L. The main line of hormone therapy and hormonal prevention of endometriosis at the present stage of medical development. Rossiiskii vestnik akushera-ginekologa. 2020;20:3:90-93. (In Russ.). https://doi.org/10.17116/rosakush20202003190
Patel BG, Rudnicki M, Yu J, Shu Y, Taylor RN. Progesterone resistance in endometriosis: origins, consequences and interventions. Acta Obstet Gynecol Scand. 2017;96:6:623-663. https://doi.org/10.1111/aogs.13156
Abdou AM, Ammar IMM, Alnemr AAA, Abdelrhman A. Dienogest versus leuprolide acetate for recurrent pelvic pain following laparoscopic treatment of endometriosis. The Journal of Obstetrics and Gyncology of India. 2018;68:4:306-313.
Takaesu Y, Nishi H, Kojima J, Sasaki T, Nagamitsu Y, Kato R, Isaka K. Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis. Journal of Obstetrics and Gynaecology Research. 2016;42:9:1152-1158.
RLS 2019, ATH Code: L02AE01.

Close metadata